medroxyprogesterone acetate has been researched along with Endometrioma in 121 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (23.14) | 18.7374 |
1990's | 27 (22.31) | 18.2507 |
2000's | 31 (25.62) | 29.6817 |
2010's | 30 (24.79) | 24.3611 |
2020's | 5 (4.13) | 2.80 |
Authors | Studies |
---|---|
Chang, CC; Chen, CC; Fu, CF; Huang, CY; Huang, SJ; Lai, JC; Shiu, LY; Yu, YC | 1 |
Du, T; Gao, H; Guo, H; Lyu, Q; Wu, L; Xi, Q; Zhu, Q | 1 |
Cai, H; Lang, J | 1 |
Hosseini, L; Hosseini, R; Rastad, H; Rodi, H; Vahid-Dastjerdi, M | 1 |
Baston-Büst, D; Bielfeld, AP; Grümmer, R; Moyer, J; Platt, F; Singer, BB; Wennemuth, G | 1 |
Bersinger, NA; Facchinetti, F; Grandi, G; McKinnon, BD; Mueller, MD | 1 |
Ai, A; Chai, W; Chen, Q; Fu, Y; Guo, H; Kuang, Y; Lyu, Q; Sun, L; Wang, Y | 1 |
Barra, F; Ferrero, S; Scala, C | 1 |
Changklungmoa, N; Chansela, P; Lertvikool, S; Poljaroen, J; Sobhon, P; Songkoomkrong, S; Sophonsritsuk, A; Sroyraya, M; Tawarasumida, Y; Tingthanatikul, Y; Weerakiet, S | 1 |
Changklungmoa, N; Lertvikool, S; Poljaroen, J; Sobhon, P; Songkoomkrong, S; Sophonsritsuk, A; Sroyraya, M; Tingthanatikul, Y; Weerakiet, S; Wongkularb, A | 1 |
Medeiros, FDC; Pereira, FEXG; Rocha, HAL; Silva, KSD | 1 |
Aslan, E; Ciftci, S; Dogruer, G; Dolapcioglu, K; Ergun, Y; Ozsoy, S; Soylu Karapinar, O | 1 |
Cheewadhanaraks, S | 1 |
Almeida, PR; Dias, BH; Guimarães, SB; Medeiros, Fd; Pereira, FE; Vasconcelos, PR | 1 |
McLaren, JS; Morris, EP; Rymer, J; Simpson, PD | 1 |
Jitruckthai, P | 1 |
Altan, M; Bruner-Tran, KL; Denis, D; Gotteland, JP; Nataraja, SG; Osteen, KG; Palmer, SS; Tos, EG | 1 |
Chai, DC; D'Hooghe, TM; Gotteland, JP; Hussein, M; Kyama, CM; Mwenda, JM; Palmer, SS | 1 |
Chen, HS; Hsieh, TH; Hsu, CY; Hsu, YL; Liang, PI; Tsai, CF; Tsai, EM | 1 |
Dragoman, MV; Gaffield, ME | 1 |
Chen, YJ; Huang, BS; Tsai, HW; Twu, NF; Wang, PH; Yen, MS | 1 |
Bifulco, G; Biscione, A; Luisi, S; Morgante, G; Petraglia, F; Tosti, C | 1 |
Bersinger, N; Cagnacci, A; Grandi, G; McKinnon, B; Mueller, M; Nirgianakis, K; Papadia, A | 1 |
Connolly, MA; Trentalange, M; Zeiss, CJ | 1 |
Bhattacharya, S; Daniels, JP; Middleton, LJ; Weckesser, A | 1 |
Apgar, BS; Levy, BS; Surrey, ES; Wysocki, S | 1 |
Jenkinson, C; Jones, G; Kennedy, S | 1 |
Berrodin, TJ; Butera, JA; Graciani, N; Jelinsky, SA; Nagpal, S; Winneker, RC; Yudt, MR; Zhang, Z | 1 |
Huber, J; Kurz, C; Pernicka, E; Unfried, G; van Trotsenburg, M; Walch, K; Wenzl, R | 1 |
Al Kadri, H; Al-Fozan, HM; Hajeer, A; Hassan, S | 1 |
Chae, HD; Kang, BM; Kim, CH; Kim, SH; Kim, YH; Koo, YH; Lee, HW; Lee, PR | 1 |
Abbiati, A; Barbara, G; Fedele, L; Somigliana, E; Vercellini, P; Viganò, P | 1 |
Bunyapipat, S; Cheewadhanaraks, S; Choksuchat, C; Choobun, T; Dhanaworavibul, K; Peeyananjarassri, K | 1 |
Doyle, JO; Laufer, MR; Missmer, SA | 1 |
Chen, X; Hu, WG; Hua, KQ; Wang, YQ; Zhang, SF; Zhu, J | 1 |
Drappeau, D; Eyster, KM; Hansen, KA; Klinkova, O; Mark-Kappeler, CJ; Winterton, E | 1 |
Chin, RK; Tang, LC; Wong, AY | 1 |
Dennerstein, GJ; Fernando, S | 1 |
Basu, A; Haran, M; Nair, A | 1 |
Cooper, M; Reid, G; Tsaltas, J | 1 |
Baum, ST; Colman, RJ; Cruzen, CL | 1 |
Akhtar, M; Brown, J; Kives, S | 1 |
Cheewadhanaraks, S; Choksuchat, C; Dhanaworavibul, K; Liabsuetrakul, T | 1 |
Beranič, N; Rižner, TL | 1 |
Beranič, N; Lanišnik Rižner, T | 1 |
Milki, AA; Tazuke, SI | 1 |
Winkel, CA | 1 |
Adams-Huet, B; Bradshaw, KD; Breslau, NA; Carr, BR; Peng, N; Steinkampf, MP | 1 |
Lei, ZW; Lü, JQ; Sun, J; Xu, XW; Zhou, J | 1 |
Bergqvist, A; Crosignani, PG; Luciano, A; Ray, A | 1 |
Bergqvist, A; Carson, SA; Luciano, A; Ross, D; Schlaff, WD | 1 |
Chen, MJ; Chen, YC; Ho, HN; Wu, MY; Yang, JH; Yang, YS | 1 |
Fazleabas, AT; Guo, SW; Hastings, JM; Jackson, KS; Kim, JJ; Ladhani, O; Lu, Z; Taylor, HS; Wu, Y | 1 |
Cetinkaya, MB; Kandemir, B; Kefeli, M; Kokcu, A; Ocal, G; Tosun, M | 1 |
Chegini, N; Luo, X; Pan, Q; Toloubeydokhti, T | 1 |
Carstensen, A; Mundhenke, C; Schollmeyer, T | 1 |
DeSilva, NK; Elliott, MM; Middleman, AB | 1 |
Apa, R; Bompiani, A; Campo, S; Gangale, MF; Lanzone, A; Minici, F; Orlando, M; Romani, F; Tiberi, F; Tropea, A | 1 |
Donadio, C; Giovannini, M; Rendina, GM | 1 |
Hatcher, RA; Maine, D; Rochat, R; Rosenfield, A; Shelton, J | 1 |
Gantt, PA; Hunt, JB; McDonough, PG | 1 |
Crook, D; Dowsett, M; Edmonds, DK; Howell, R; Lees, B; Stevenson, JC | 1 |
Healy, DL; Wingfield, M | 1 |
Edmonds, DK; Howell, R | 1 |
Benagiano, G; Marziani, R; Mossa, B; Napolitano, C; Perniola, L | 1 |
Bergqvist, A; Ljungberg, O; Skoog, L | 1 |
Dowsett, M; Edmonds, DK; Howell, R; King, N | 1 |
Kauppila, A; Mäkäräinen, L; Rönnberg, L | 1 |
Cahill, DJ; Harlow, CR; Hull, MG; Wardle, PG | 1 |
Cortesi, I; Crosignani, PG; De Giorgi, O; Oldani, S; Panazza, S; Vercellini, P | 1 |
Ferrara, N; Jaffe, RB; Meng, YG; Ryan, IP; Shifren, JL; Taylor, RN; Tseng, JF; Zaloudek, CJ | 1 |
Edmonds, DK | 1 |
Moghissi, KS | 3 |
Kiesel, L; Schweppe, KW; Siebzehnrübl, E; Sillem, M | 1 |
Cundy, T; Reid, IR | 1 |
Montag, M; Schindler, AE; Schwack, M | 1 |
Bianchi, S; Fedele, L; Raffaelli, R; Zanconato, G | 1 |
Bland, E; Deary, AJ; Prentice, A | 1 |
Arowojolu, AO | 1 |
Bergqvist, A; Theorell, T | 1 |
Aono, T; Irahara, M; Kamada, M; Kinoshita, H; Kiyokawa, M; Tezuka, M; Uemura, H; Yamada, M; Yasui, T | 1 |
Curtin, JP; Hines, BJ; Mittal, K; Muggia, FM; Porges, RF | 1 |
Kisser, M; Mühlbauer, H; Peters-Engl, C; Pokieser, W; Schmerker, R; Ulrich, W | 1 |
Rice, VM | 1 |
Olive, DL; Pritts, EA | 1 |
Judd, HL | 1 |
Asmar, P; Paulson, JD; Saffan, DS | 1 |
Haney, AF; Lessey, BA; McCarty, KS; Metzger, DA; Soper, JT | 1 |
Kato, Y; Kuramoto, H; Morisawa, T | 1 |
Goldrath, MH | 1 |
Barbieri, RL | 1 |
Cedars, MI; Judd, HL; Lu, JK; Meldrum, DR | 1 |
Hattori, S; Kodama, H; Oguchi, H; Tamakoshi, K | 1 |
Leodolter, S; Marhold, W | 1 |
Bischof, P; Brioschi, PA; Herrmann, WL; Tseng, L | 1 |
Bardawil, WA; Beluhan, FZ; Bennett, BT; McCarthy, TJ | 1 |
Deligdisch, L; Goodman, HM; Kredentser, D | 1 |
Kauppila, A; Penttilä, I; Puolakka, J; Rönnberg, L; Telimaa, S | 1 |
Honjo, H; Kitawaki, J; Okada, H; Urabe, M; Yamamoto, T | 1 |
Terakawa, N | 1 |
Kauppila, AJ; Rönnberg, L; Telimaa, S | 1 |
Dmowski, WP; Radwanska, E; Rana, N | 1 |
Kotarski, J; Lipska-Rodziewicz, T; Postawski, K | 1 |
Jakowicki, J; Kotarski, J | 1 |
Fåhraeus, L; Sydsjö, A; Wallentin, L | 1 |
Hayes, MF; Hull, ME; Magyar, DF; Moghissi, KS | 1 |
Cremer, P; Kuhn, W; Nagel, GA; Seidel, D; Teichmann, AT; Wander, HE; Wieland, H | 1 |
Hayes, MF; Hull, ME; Magyar, DM; Moghissi, KS | 1 |
Kauppila, A; Rönnberg, L; Telimaa, S; Vuori, J | 1 |
Kozuka, Y; Murata, K; Sugiyama, Y; Taniguchi, H; Toyoda, N; Uematsu, A; Yamamoto, T | 1 |
Cremer, P; Kuhn, W; Seidel, D; Teichmann, AT; Wieland, H | 1 |
Carleo, J; Luciano, AA; Turksoy, RN | 1 |
Kauppila, A; Puolakka, J; Rönnberg, L; Telimaa, S | 1 |
Kauppila, A; Rönnberg, L; Telimaa, S | 1 |
Aoki, M; Ishida, M; Nagasawa, H; Sakagami, N | 1 |
Telimaa, S | 1 |
Kauppila, A; Rönnberg, L; Vierikko, P; Vihko, R | 1 |
Hamerlynck, JV; Mangioni, C; Maskens, AP; Rotmensz, N; van der Burg, ME; Vermorken, JB; Wils, JA | 1 |
Barker, AF; Dixon, LM; Elliot, DL | 1 |
16 review(s) available for medroxyprogesterone acetate and Endometrioma
Article | Year |
---|---|
Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis.
Topics: Administration, Oral; Endometriosis; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pelvic Pain; Progestins; Randomized Controlled Trials as Topic; Receptors, Steroid | 2018 |
Minimising menopausal side effects whilst treating endometriosis and fibroids.
Topics: Antineoplastic Agents, Hormonal; Bone Density; Contraceptives, Oral, Combined; Delayed-Action Preparations; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Leiomyoma; Medroxyprogesterone Acetate; Menopause; Receptors, LHRH; Uterine Neoplasms | 2015 |
The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review.
Topics: Bone Density; Contraceptive Agents, Female; Delayed-Action Preparations; Endometriosis; Female; HIV Infections; Humans; Injections, Intramuscular; Injections, Subcutaneous; Medroxyprogesterone Acetate; Obesity; Pain; Patient Satisfaction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Weight Gain; World Health Organization | 2016 |
Hormonal therapy for endometriosis: from molecular research to bedside.
Topics: Aromatase Inhibitors; Endometriosis; Female; Hormone Antagonists; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Selective Estrogen Receptor Modulators; Treatment Outcome | 2017 |
Endometriosis and chronic pain: a multispecialty roundtable discussion.
Topics: Administration, Intravaginal; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; C-Reactive Protein; Catheter Ablation; Chronic Disease; Clinical Trials as Topic; Contraceptive Agents, Female; Danazol; Diagnosis, Differential; Drug Therapy, Combination; Endometriosis; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Laparoscopy; Medroxyprogesterone Acetate; Pelvic Pain; Practice Guidelines as Topic; Reoperation; Severity of Illness Index; Treatment Outcome | 2007 |
Hormone therapy for endometriosis and surgical menopause.
Topics: Endometriosis; Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause, Premature; Norpregnenes; Pain; Postoperative Complications; Progesterone; Randomized Controlled Trials as Topic; Recurrence | 2009 |
Repetitive surgery for recurrent symptomatic endometriosis: what to do?
Topics: Adult; Danazol; Endometriosis; Female; Humans; Hysterectomy; Ligaments; Medroxyprogesterone Acetate; Ovariectomy; Pelvic Pain; Postoperative Care; Recurrence; Reoperation | 2009 |
Progestagens and anti-progestagens for pain associated with endometriosis.
Topics: Danazol; Dydrogesterone; Endometriosis; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Medroxyprogesterone Acetate; Pelvic Pain; Progesterone Congeners; Progestins | 2012 |
Evaluation and management of women with endometriosis.
Topics: Adult; CA-125 Antigen; Contraceptives, Oral; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Laparoscopy; Medroxyprogesterone Acetate; Ovarian Diseases | 2003 |
Endometriosis: medical therapy.
Topics: Danazol; Endometriosis; Estrogens; Female; Gestrinone; Goserelin; Humans; Infertility, Female; Laparoscopy; Medroxyprogesterone Acetate; Menopause; Pelvic Pain; Pregnancy; Pregnancy Outcome; Reproductive Techniques; Severity of Illness Index; Treatment Outcome | 1993 |
Medical treatment of endometriosis.
Topics: Danazol; Endometriosis; Estrogen Antagonists; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Progesterone Congeners; Pseudopregnancy; Treatment Outcome | 1999 |
Progestagens and anti-progestagens for pain associated with endometriosis.
Topics: Dydrogesterone; Endometriosis; Female; Gestrinone; Humans; Medroxyprogesterone Acetate; Pain; Progesterone Congeners; Progestins | 2000 |
Conventional medical therapies for endometriosis.
Topics: Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Medroxyprogesterone Acetate; Recurrence | 2002 |
The treatment of endometriosis: a review of the evidence.
Topics: Combined Modality Therapy; Danazol; Endometriosis; Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Pain | 2002 |
Gonadotropin-releasing hormone agonists: strategies for managing the hypoestrogenic effects of therapy.
Topics: Bone Density; Climacteric; Drug Therapy, Combination; Endometriosis; Estrogens; Female; Fertility; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Progestins | 1992 |
Pseudopregnancy induced by estrogen-progestogen or progestogens alone in the treatment of endometriosis.
Topics: Drug Therapy, Combination; Endometriosis; Estradiol Congeners; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Progestins; Pseudopregnancy | 1990 |
33 trial(s) available for medroxyprogesterone acetate and Endometrioma
Article | Year |
---|---|
The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial.
Topics: Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Ovulation Induction; Pregnancy; Progestins; Prospective Studies | 2022 |
Comparison of the effectiveness of Dienogest with medroxyprogesterone acetate in the treatment of pelvic pain and recurrence of endometriosis after laparoscopic surgery.
Topics: Endometriosis; Female; Humans; Laparoscopy; Medroxyprogesterone Acetate; Nandrolone; Pelvic Pain | 2023 |
DMPA Suppresses Cell Proliferation and Enhances Cell Apoptosis of Eutopic Endometrium in Women with Endometriosis: A Randomized Controlled Study.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Cell Proliferation; Endometriosis; Endometrium; Female; Humans; Medroxyprogesterone Acetate | 2016 |
Low-dose add-back therapy during postoperative GnRH agonist treatment.
Topics: Adult; Bone Density; Drug Combinations; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Hormone Replacement Therapy; Hot Flashes; Humans; Leuprolide; Medroxyprogesterone Acetate; Patient Dropouts; Prospective Studies; Sleep Initiation and Maintenance Disorders | 2016 |
Preventing recurrence of endometriosis by means of long-acting progestogen therapy (PRE-EMPT): report of an internal pilot, multi-arm, randomised controlled trial incorporating flexible entry design and adaption of design based on feasibility of recruitme
Topics: Adolescent; Adult; Clinical Protocols; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Endometriosis; Feasibility Studies; Female; Humans; Injections; Intrauterine Devices; Laparoscopy; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Patient Selection; Pilot Projects; Progestins; Recurrence; Research Design; Secondary Prevention; Time Factors; Treatment Outcome; United Kingdom; Young Adult | 2017 |
Evaluation of the American version of the 30-item Endometriosis Health Profile (EHP-30).
Topics: Adult; Antineoplastic Agents, Hormonal; Endometriosis; Female; Health Status; Humans; Leuprolide; Medroxyprogesterone Acetate; Psychometrics; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; United States | 2008 |
Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis--a pilot study.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Endometriosis; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Middle Aged; Palliative Care; Pelvic Pain; Pilot Projects; Prospective Studies; Treatment Outcome; Young Adult | 2009 |
Interval of injections of intramuscular depot medroxyprogesterone acetate in the long-term treatment of endometriosis-associated pain: a randomized comparative trial.
Topics: Adult; Delayed-Action Preparations; Drug Administration Schedule; Endometriosis; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Pain; Patient Satisfaction; Patient Selection; Premenopause; Time Factors | 2009 |
[Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis].
Topics: Administration, Cutaneous; Administration, Oral; Adult; Calcitonin; Drug Therapy, Combination; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Medroxyprogesterone Acetate; Menstrual Cycle; Pain; Treatment Outcome | 2009 |
Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial.
Topics: Adult; Contraceptive Agents, Female; Endometriosis; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate | 2010 |
Postoperative depot medroxyprogesterone acetate versus continuous oral contraceptive pills in the treatment of endometriosis-associated pain: a randomized comparative trial.
Topics: Adult; Analgesia; Contraceptives, Oral; Delayed-Action Preparations; Endometriosis; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norpregnenes; Pain Measurement; Postoperative Care; Treatment Outcome | 2012 |
Effect of gonadotropin-releasing hormone agonist and medroxyprogesterone acetate on calcium metabolism: a prospective, randomized, double-blind, placebo-controlled, crossover trial.
Topics: Adult; Bone Density; Calcium; Cross-Over Studies; Double-Blind Method; Endometriosis; Female; Gonadotropin-Releasing Hormone; Homeostasis; Humans; Leiomyomatosis; Leuprolide; Medroxyprogesterone Acetate; Placebos; Uterine Neoplasms | 2003 |
Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain.
Topics: Administration, Cutaneous; Adult; Antineoplastic Agents, Hormonal; Bone Density; Contraceptive Agents, Female; Endometriosis; Female; Fertility Agents, Female; Hip; Humans; Leuprolide; Lumbar Vertebrae; Medroxyprogesterone Acetate; Pelvic Pain; Quality of Life; Radiography; Treatment Outcome; Uterine Diseases | 2006 |
Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
Topics: Adult; Bone Density; Delayed-Action Preparations; Endometriosis; Estrogens; Female; Flushing; Humans; Injections, Subcutaneous; Leuprolide; Medroxyprogesterone Acetate; Pain; Palliative Care; Quality of Life; Single-Blind Method; Treatment Outcome; Uterine Hemorrhage | 2006 |
Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
Topics: Adult; Bone Density; Endometriosis; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Goserelin; Humans; Lipids; Luteinizing Hormone; Medroxyprogesterone Acetate; Premenopause; Prospective Studies | 1995 |
Can hormone replacement therapy be used during medical therapy of endometriosis?
Topics: Bone Density; Endometriosis; Estradiol; Estrogen Replacement Therapy; Female; Goserelin; Humans; Medroxyprogesterone Acetate; Treatment Outcome | 1994 |
Endocrine effects of GnRH analogue with low-dose hormone replacement therapy in women with endometriosis.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometriosis; Estradiol; Estrogen Replacement Therapy; Estrone; Feedback; Female; Follicle Stimulating Hormone; Goserelin; Humans; Inhibins; Luteinizing Hormone; Medroxyprogesterone Acetate; Prospective Studies | 1995 |
Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis.
Topics: Adult; Double-Blind Method; Drug Therapy, Combination; Endometriosis; Estrogen Antagonists; Female; Goserelin; Humans; Medroxyprogesterone Acetate; Sex Hormone-Binding Globulin | 1996 |
Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis.
Topics: Adolescent; Adult; Contraceptives, Oral; Danazol; Delayed-Action Preparations; Drug Therapy, Combination; Endometriosis; Female; Humans; Medroxyprogesterone Acetate; Palliative Care; Pelvic Pain; Time Factors | 1996 |
Add-back therapy in the treatment of endometriosis: the European experience.
Topics: Administration, Cutaneous; Bone Density; Double-Blind Method; Drug Combinations; Endometriosis; Estradiol; Estrogen Replacement Therapy; Female; Goserelin; Humans; Injections; Luteinizing Hormone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Treatment Outcome | 1996 |
Add-back therapy in the treatment of endometriosis: the North American experience.
Topics: Administration, Oral; Bone Density; Double-Blind Method; Endometriosis; Estrogen Replacement Therapy; Female; Goserelin; Humans; Medroxyprogesterone Acetate; Osteoporosis; Prospective Studies | 1996 |
Should add-back therapy for endometriosis be deferred for optimal results?
Topics: Bone Density; Double-Blind Method; Drug Therapy, Combination; Endometriosis; Female; Goserelin; Humans; Medroxyprogesterone Acetate; Premenopause; Prospective Studies | 1996 |
Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Anabolic Agents; Endometriosis; Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Ovariectomy; Pelvis | 1999 |
Treatment of endometriosis with depot medroxyprogesterone acetate: a preliminary experience.
Topics: Acne Vulgaris; Adult; Delayed-Action Preparations; Drug Costs; Endometriosis; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Menorrhagia; Menstruation Disturbances; Pain; Progesterone Congeners; Severity of Illness Index; Treatment Outcome | 2000 |
Changes in quality of life after hormonal treatment of endometriosis.
Topics: Adolescent; Adult; Anxiety; Depression; Double-Blind Method; Endometriosis; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Nafarelin; Patient Dropouts; Pelvic Pain; Progesterone Congeners; Prospective Studies; Quality of Life; Sleep Wake Disorders; Statistics, Nonparametric; Surveys and Questionnaires | 2001 |
Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis.
Topics: Adult; Animals; Bone Density; Bone Remodeling; CA-125 Antigen; Endometriosis; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Gonadotropin-Releasing Hormone; Horses; Humans; Leuprolide; Medroxyprogesterone Acetate; Middle Aged; Uterine Hemorrhage | 2001 |
Circulating lipid and lipoprotein concentrations during danazol and high-dose medroxyprogesterone acetate therapy of endometriosis.
Topics: Adult; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Danazol; Endometriosis; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Triglycerides | 1989 |
Steroidal drugs in endometriosis.
Topics: Antineoplastic Agents; Danazol; Double-Blind Method; Endometriosis; Female; Genital Neoplasms, Female; Gestrinone; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norpregnatrienes; Pregnadienes; Pregnancy; Randomized Controlled Trials as Topic | 1989 |
Medroxyprogesterone acetate and lipid metabolic changes.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Breast Neoplasms; Cholesterol; Endometriosis; Female; Humans; Lipid Metabolism; Lipids; Lipoproteins; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Triglycerides; Uterine Neoplasms | 1987 |
Placebo-controlled study on serum concentrations of CA-125 before and after treatment of endometriosis with danazol or high-dose medroxyprogesterone acetate alone or after surgery.
Topics: Antigens, Neoplasm; Antigens, Surface; Antigens, Tumor-Associated, Carbohydrate; Clinical Trials as Topic; Danazol; Delayed-Action Preparations; Endometriosis; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Placebos; Pregnadienes | 1988 |
Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis.
Topics: Adult; Antineoplastic Agents; Clinical Trials as Topic; Danazol; Dose-Response Relationship, Drug; Double-Blind Method; Endometriosis; Female; Humans; Infertility, Female; Laparoscopy; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Pelvic Neoplasms; Pregnadienes; Pregnancy; Random Allocation | 1987 |
Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery.
Topics: Analysis of Variance; Danazol; Double-Blind Method; Endometriosis; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Postoperative Care; Pregnadienes; Random Allocation | 1987 |
Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosis.
Topics: Adult; Clinical Trials as Topic; Danazol; Endometriosis; Female; Humans; Infertility, Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Pregnancy | 1988 |
72 other study(ies) available for medroxyprogesterone acetate and Endometrioma
Article | Year |
---|---|
Combinatory effects of current regimens and Guizhi Fuling Wan on the development of endometriosis.
Topics: Animals; Drugs, Chinese Herbal; Endometriosis; Female; Gestrinone; Intercellular Adhesion Molecule-1; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Vascular Endothelial Growth Factor A | 2022 |
Long non‑coding RNA LINC01960‑201 hinders decidualization of endometrial stromal cell in endometriosis: Relevance to endometrial receptivity.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; ADAMTS7 Protein; Blood Substitutes; Decidua; Disintegrins; Endometriosis; Endometrium; Female; Humans; Infertility; Medroxyprogesterone Acetate; MicroRNAs; Pregnancy; RNA, Long Noncoding; Stromal Cells; Thrombospondins; Untranslated Regions | 2022 |
Forskolin versus cAMP-Induced Decidualization and Survival of Endometrial Stromal Cells of Endometriosis Patients.
Topics: Cells, Cultured; Colforsin; Decidua; Endometriosis; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Progesterone; Progestins; Prolactin; Stromal Cells | 2023 |
The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
Topics: Adult; Cytokines; Endometriosis; Endometrium; Female; Humans; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid; Stromal Cells; Tumor Necrosis Factor-alpha | 2017 |
Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization.
Topics: Adult; Case-Control Studies; Contraceptive Agents, Female; Endometriosis; Female; Fertilization in Vitro; Humans; Medroxyprogesterone Acetate; Ovulation Induction; Pregnancy; Pregnancy Outcome; Retrospective Studies; Young Adult | 2017 |
Differential expressions of estrogen and progesterone receptors in endometria and cyst walls of ovarian endometrioma from women with endometriosis and their responses to depo-medroxyprogesterone acetate treatment.
Topics: Adult; Cell Count; Cysts; Endometriosis; Endometrium; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Receptors, Progesterone | 2018 |
Effects of omega-6/3 and omega-9/6 nutraceuticals on pain and fertility in peritoneal endometriosis in rats.
Topics: Animals; Disease Models, Animal; Endometriosis; Fatty Acids, Omega-3; Female; Fertility; Medroxyprogesterone Acetate; Meloxicam; Pain; Peritoneum; Rats | 2019 |
Theranekron for treatment of endometriosis in a rat model compared with medroxyprogesterone acetate and leuprolide acetate.
Topics: Animals; Antineoplastic Agents, Hormonal; Disease Models, Animal; Endometriosis; Endometrium; Female; Leuprolide; Medroxyprogesterone Acetate; Random Allocation; Rats; Secondary Prevention; Spider Venoms | 2013 |
Cumulative recurrence rates of endometriosis-associated pain after long-term intramuscular depot medroxyprogesterone acetate therapy.
Topics: Adult; Delayed-Action Preparations; Endometriosis; Female; Humans; Medroxyprogesterone Acetate; Recurrence | 2013 |
Development of a subcutaneous endometriosis rat model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Hormonal; Aspirin; Connective Tissue Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Endometriosis; Estradiol; Estrogens; Female; Medroxyprogesterone Acetate; Rats, Wistar; Reproducibility of Results; Subcutaneous Tissue; Time Factors; Triptorelin Pamoate | 2015 |
A Woman with Recurrent Hemoptysis, a Rare Etiology.
Topics: Adult; Bronchi; Bronchoscopy; Endometriosis; Female; Follow-Up Studies; Hemoptysis; Humans; Lung; Medroxyprogesterone Acetate; Menstrual Cycle; Radiography | 2015 |
Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models.
Topics: Adult; Animals; Benzothiazoles; Cytokines; Disease Models, Animal; Endometriosis; Endometrium; Enzyme Inhibitors; Female; Humans; JNK Mitogen-Activated Protein Kinases; Killer Cells, Natural; MAP Kinase Signaling System; Matrix Metalloproteinase 3; Medroxyprogesterone Acetate; Mice; Mice, Nude; Progesterone; Pyrimidines; Rats | 2016 |
c-Jun NH2-terminal kinase inhibitor bentamapimod reduces induced endometriosis in baboons: an assessor-blind placebo-controlled randomized study.
Topics: Animals; Benzothiazoles; Disease Models, Animal; Drug Therapy, Combination; Endometriosis; Endometrium; Female; Gonadotropin-Releasing Hormone; Hormones; JNK Mitogen-Activated Protein Kinases; Laparoscopy; Medroxyprogesterone Acetate; Menstrual Cycle; Papio anubis; Protein Kinase Inhibitors; Pyrimidines; Random Allocation; Signal Transduction; Time Factors | 2016 |
Synthetic Steroid Hormones Regulated Cell Proliferation Through MicroRNA-34a-5p in Human Ovarian Endometrioma.
Topics: Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Danazol; Endometriosis; Estradiol; Female; Gene Expression Regulation; Humans; Medroxyprogesterone Acetate; Mice; MicroRNAs; Ovarian Diseases; Progesterone; Receptor, Notch1; Transcriptome; Up-Regulation | 2016 |
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells.
Topics: Cell Proliferation; Cell Survival; Cells, Cultured; Cellular Microenvironment; Cytokines; Endometriosis; Endometrium; Estrogens; Female; Humans; Immunosuppression Therapy; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Stromal Cells; Tumor Necrosis Factor-alpha | 2016 |
Long-Term Clinical Outcomes in Diabetic Rhesus Macaques (Macaca mulatta) Treated with Medroxyprogesterone Acetate for Endometriosis.
Topics: Animals; Delayed-Action Preparations; Diabetes Complications; Endometriosis; Female; Macaca mulatta; Medroxyprogesterone Acetate; Monkey Diseases; Retrospective Studies; Treatment Outcome | 2016 |
Novel progesterone receptor modulators with gene selective and context-dependent partial agonism.
Topics: Androgen Receptor Antagonists; Animals; Chlorocebus aethiops; Contraceptive Agents, Female; COS Cells; Endometriosis; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Medroxyprogesterone Acetate; Piperazines; Polymerase Chain Reaction; Progestins; Receptors, Progesterone | 2009 |
Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis.
Topics: Adult; Cell Line; Down-Regulation; Endometriosis; Endometrium; Estradiol; Female; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Menstrual Cycle; p21-Activated Kinases; Progestins; RNA, Small Interfering; Signal Transduction; Transfection | 2009 |
The effect of combined surgical-medical intervention on the progression of endometriosis in an adolescent and young adult population.
Topics: Adolescent; Child; Combined Modality Therapy; Contraceptives, Oral, Combined; Disease Progression; Electrocoagulation; Endometriosis; Female; Fertility Agents, Female; Humans; Laparoscopy; Lasers, Gas; Leuprolide; Medroxyprogesterone Acetate; Peritoneal Diseases; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
Reciprocal communication between endometrial stromal cells and macrophages.
Topics: Culture Media, Conditioned; Endometriosis; Endometrium; Estradiol; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Macrophages; Medroxyprogesterone Acetate; Oligonucleotide Array Sequence Analysis; Paracrine Communication; Prolactin; Reverse Transcriptase Polymerase Chain Reaction; Stromal Cells; U937 Cells | 2010 |
Bowel resection for severe endometriosis: an Australian series of 177 cases.
Topics: Contraceptive Agents, Female; Digestive System Surgical Procedures; Endometriosis; Female; Humans; Intestinal Diseases; Intestines; Medroxyprogesterone Acetate | 2010 |
Letter in response to Levonorgestrel-releasing intrauterine system (Mirena®) and Depot medroxyprogesterone acetate (Depo-Provera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised trial by Wong AYK, Tang LC
Topics: Contraceptive Agents, Female; Endometriosis; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Randomized Controlled Trials as Topic; Severity of Illness Index | 2011 |
Response to Dennerstein letter: Bowel resection for severe endometriosis: an Australian series of 177 cases.
Topics: Australia; Colonic Diseases; Colorectal Surgery; Contraceptive Agents, Female; Endometriosis; Female; Humans; Medroxyprogesterone Acetate; Severity of Illness Index | 2011 |
Glucoregulatory function in adult rhesus macaques (Macaca mulatta) undergoing treatment with medroxyprogesterone acetate for endometriosis.
Topics: Animals; Animals, Laboratory; Blood Glucose; Cross-Sectional Studies; Endometriosis; Female; Insulin Resistance; Longitudinal Studies; Macaca mulatta; Medroxyprogesterone Acetate; Monkey Diseases; Time Factors | 2011 |
Effects of progestins on local estradiol biosynthesis and action in the Z-12 endometriotic epithelial cell line.
Topics: Aromatase; Cell Line; Cell Membrane; Cell Nucleus; Dydrogesterone; Endometriosis; Epithelial Cells; Estradiol; Estradiol Dehydrogenases; Estrogen Receptor alpha; Female; Gene Expression Regulation, Enzymologic; Humans; Medroxyprogesterone Acetate; Nandrolone; Progestins; Receptors, Estrogen; Receptors, G-Protein-Coupled | 2012 |
Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aldo-Keto Reductase Family 1 Member C3; Cells, Cultured; Down-Regulation; Dydrogesterone; Endometriosis; Endometrium; Epithelial Cells; Estradiol Dehydrogenases; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Hydroxysteroid Dehydrogenases; Medroxyprogesterone Acetate; Membrane Proteins; Nandrolone; Progesterone; Progestins; Receptors, Progesterone; RNA, Messenger | 2013 |
Endometrioma of uterine serosa in a woman with mosaic Turner's syndrome receiving hormone replacement therapy: case report.
Topics: Adult; Endometriosis; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Mosaicism; Turner Syndrome; Uterine Diseases | 2002 |
[Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
Topics: Adult; Combined Modality Therapy; Delayed-Action Preparations; Drug Administration Schedule; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Leuprolide; Luteinizing Hormone; Medroxyprogesterone Acetate; Treatment Outcome; Uterine Hemorrhage | 2005 |
Decreased suppression of interleukin-6 after treatment with medroxyprogesterone acetate and danazol in endometrial stromal cells of women with adenomyosis.
Topics: Cells, Cultured; Cohort Studies; Contraceptive Agents, Female; Danazol; Drug Combinations; Endometriosis; Endometrium; Estrogen Antagonists; Female; Gene Expression; Humans; Interleukin-6; Medroxyprogesterone Acetate; Stromal Cells; Uterine Diseases | 2006 |
Altered expression of HOXA10 in endometriosis: potential role in decidualization.
Topics: Animals; Bucladesine; Cells, Cultured; Decidua; DNA Methylation; Endometriosis; Endometrium; Epithelial Cells; Estradiol; Female; Gene Expression Regulation; Gene Silencing; Homeobox A10 Proteins; Homeodomain Proteins; Humans; Insulin-Like Growth Factor Binding Protein 1; Medroxyprogesterone Acetate; Papio; Promoter Regions, Genetic; RNA, Messenger; Stromal Cells; Transcription Factors | 2007 |
Efficacy of levamisole on experimental endometriosis.
Topics: Adjuvants, Immunologic; Animals; Contraceptive Agents, Female; Delayed-Action Preparations; Disease Models, Animal; Endometriosis; Female; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Injections, Intramuscular; Injections, Subcutaneous; Leuprolide; Levamisole; Medroxyprogesterone Acetate; Random Allocation; Rats; Rats, Wistar | 2007 |
The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression.
Topics: Adult; Endometriosis; Endometrium; Estradiol; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Medroxyprogesterone Acetate; MicroRNAs; Oligonucleotide Array Sequence Analysis; Ovary; Polymerase Chain Reaction; Steroids | 2007 |
[Endometriosis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Buserelin; Complementary Therapies; Contraceptive Agents, Female; Cyclooxygenase 2 Inhibitors; Dysmenorrhea; Endometriosis; Female; Fertility Agents, Female; Humans; Infertility, Female; Leuprolide; Medroxyprogesterone Acetate; Middle Aged; Postoperative Care; Pregnancy; Time Factors | 2007 |
Sexual activity and teenage females taking hormonal therapy for medical indications.
Topics: Adolescent; Adolescent Behavior; Adolescent Medicine; Case-Control Studies; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Endometriosis; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menstruation Disturbances; Ovarian Cysts; Primary Ovarian Insufficiency; Retrospective Studies; Sexual Behavior | 2007 |
Endometriosis and human infertility: a new investigation into the role of eutopic endometrium.
Topics: Adult; Ascitic Fluid; Decidua; Endometriosis; Endometrium; Estradiol; Female; Humans; Infertility, Female; Insulin-Like Growth Factor Binding Protein 1; Medroxyprogesterone Acetate; Prolactin; Tumor Necrosis Factor-alpha | 2008 |
Steroid receptors and progestinic therapy in ovarian endometrioid carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Endometriosis; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone | 1982 |
The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
Topics: Delayed-Action Preparations; Developing Countries; Drug Evaluation; Endometriosis; Family Planning Services; Female; Humans; Injections; Legislation, Drug; Medroxyprogesterone; Medroxyprogesterone Acetate; Risk; United States; Uterine Neoplasms; World Health Organization | 1983 |
Progestin reversal of ureteral endometriosis.
Topics: Adult; Delayed-Action Preparations; Endometriosis; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Ureteral Obstruction | 1981 |
Management of stage III and IV endometriosis: a 10-year experience.
Topics: Combined Modality Therapy; Danazol; Endometriosis; Female; Humans; Infertility, Female; Laparoscopy; Medroxyprogesterone Acetate; Menstruation Disturbances; Microsurgery; Pain; Pregnancy; Reoperation; Retrospective Studies | 1994 |
Immunohistochemical analysis of oestrogen and progesterone receptors in endometriotic tissue and endometrium.
Topics: Adult; Antibodies, Monoclonal; Danazol; Endometriosis; Endometrium; Female; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Menstruation; Receptors, Estrogen; Receptors, Progesterone | 1993 |
Effect of progestogen therapy on follicular development, related hormone concentrations and fertilization in vitro in unstimulated cycles and unexplained and endometriosis-associated infertility.
Topics: Case-Control Studies; Endometriosis; Female; Fertilization in Vitro; Follicular Fluid; Hormones; Humans; Infertility, Female; Luteinizing Hormone; Male; Medroxyprogesterone Acetate; Menstrual Cycle; Ovarian Follicle; Ovary; Pituitary Gland; Pregnancy | 1996 |
Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis.
Topics: Cells, Cultured; Endometriosis; Endometrium; Endothelial Growth Factors; Estradiol; Female; Humans; Lymphokines; Medroxyprogesterone Acetate; Menstrual Cycle; Neovascularization, Physiologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1996 |
Bone loss and depot medroxyprogesterone.
Topics: Endometriosis; Female; Humans; Medroxyprogesterone Acetate; Osteoporosis; Pelvic Pain | 1997 |
[Parenchymal thoracic endometriosis--diagnosis and therapy].
Topics: Adult; Angiography; Antineoplastic Agents, Hormonal; Diagnosis, Differential; Drug Therapy, Combination; Endometriosis; Fallopian Tubes; Female; Hemoptysis; Humans; Laparoscopy; Leuprolide; Lung Diseases; Medroxyprogesterone Acetate | 1997 |
Use of medroxyprogesterone acetate in the treatment of Müllerian adenosarcoma: a case report.
Topics: Adenosarcoma; Adult; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Endometriosis; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone Acetate; Mixed Tumor, Mullerian | 2002 |
Clear cell carcinoma arising in endometriosis of the rectum following progestin therapy.
Topics: Adenocarcinoma, Clear Cell; Adult; Constriction, Pathologic; Endometriosis; Fatal Outcome; Female; Humans; Medroxyprogesterone Acetate; Periodic Acid-Schiff Reaction; Progesterone Congeners; Rectal Neoplasms; Rectum | 2002 |
Mild and moderate endometriosis. Comparison of treatment modalities for infertile couples.
Topics: Adult; Antineoplastic Agents; Cautery; Danazol; Endometriosis; Female; Follow-Up Studies; Humans; Infertility, Female; Laparoscopy; Laparotomy; Laser Therapy; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Retrospective Studies; Uterine Neoplasms | 1991 |
Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content.
Topics: Adult; Antineoplastic Agents; Endometriosis; Female; Humans; Hysterectomy; Immunohistochemistry; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Ovariectomy; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms | 1991 |
[Growth regulation of sex steroid hormone in endometrial carcinoma transplanted into nude mice].
Topics: Adenocarcinoma; Animals; Cell Division; Endometriosis; Estradiol; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured; Uterine Neoplasms | 1991 |
Use of danazol in hysteroscopic surgery for menorrhagia.
Topics: Adolescent; Adult; Danazol; Drug Synergism; Endometriosis; Female; Humans; Hysteroscopy; Laser Therapy; Medroxyprogesterone; Medroxyprogesterone Acetate; Menorrhagia; Middle Aged; Pregnadienes; Premedication; Uterine Hemorrhage; Warfarin | 1990 |
Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
Topics: Drug Therapy, Combination; Endometriosis; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Uterine Neoplasms | 1990 |
Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
Topics: Adult; Drug Therapy, Combination; Endometriosis; Estradiol; Estrone; Female; Flushing; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Pain; Pelvic Neoplasms | 1990 |
[A case of endometriosis with massive ascites].
Topics: Antineoplastic Agents; Ascitic Fluid; Combined Modality Therapy; Endometriosis; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged | 1990 |
[Catamenial pneumothorax--endometriosis as a multidisciplinary challenge].
Topics: Adult; Combined Modality Therapy; Contraceptive Agents, Female; Endometriosis; Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Ovariectomy; Pleural Neoplasms; Pneumothorax | 1990 |
Cancer antigen 125 is produced by human endometrial stromal cells.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Cells, Cultured; Cycloheximide; Danazol; Endometriosis; Endometrium; Epitopes; Estradiol; Estrenes; Female; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mifepristone; Triptorelin Pamoate | 1986 |
Pyometra in a rhesus monkey secondary to prolonged therapy with medroxyprogesterone acetate.
Topics: Animals; Endometriosis; Endometritis; Female; Macaca; Macaca mulatta; Medroxyprogesterone; Medroxyprogesterone Acetate; Monkey Diseases; Uterus | 1989 |
Postmenopausal endometriosis associated with hormone replacement therapy. A case report.
Topics: Endometriosis; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Peritoneal Neoplasms | 1989 |
Estrogen biosynthesis in human uterine adenomyosis.
Topics: Adult; Aromatase; Cells, Cultured; Danazol; Endometriosis; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progesterone; Uterine Neoplasms | 1989 |
[Studies on endocrine therapy of endometriosis].
Topics: Animals; Buserelin; Danazol; Drug Therapy, Combination; Endometriosis; Estradiol; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Pregnadienes; Rats; Rats, Inbred Strains | 1989 |
Recurrent endometriosis following hysterectomy and oophorectomy: the role of residual ovarian fragments.
Topics: Adult; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypertrophy; Hysterectomy; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovariectomy; Ovary; Postoperative Complications; Recurrence | 1988 |
[Evaluation of the effectiveness of the combined treatment of advanced forms of endometriosis in young women].
Topics: Adult; Endometriosis; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Staging; Ovarian Neoplasms | 1985 |
[Effect of medroxyprogesterone (MPA) on blood levels of FSH, LH and prolactin in women].
Topics: Adult; Endometriosis; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Cysts; Ovarian Neoplasms; Prolactin | 1985 |
Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate.
Topics: Adult; Cholesterol, HDL; Delayed-Action Preparations; Endometriosis; Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Pelvic Neoplasms; Phospholipids; Triglycerides | 1986 |
Comparison of different treatment modalities of endometriosis in infertile women.
Topics: Adult; Antineoplastic Agents; Danazol; Endometriosis; Female; Follow-Up Studies; Humans; Infertility, Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Pelvic Neoplasms; Pregnadienes | 1987 |
Comparison of different treatment modalities of endometriosis in infertile women.
Topics: Danazol; Endometriosis; Female; Genital Neoplasms, Female; Humans; Infertility, Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy | 1987 |
[A case of stromal endometriosis (endolymphatic stromal myosis) in the effective treatment with progestogen].
Topics: Adult; Endometriosis; Female; Humans; Hysterectomy; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Pneumonectomy; Uterine Neoplasms | 1988 |
Lipid metabolic changes during hormonal treatment of endometriosis.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Danazol; Endometriosis; Female; Humans; Lipid Metabolism; Lynestrenol; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pelvic Neoplasms; Pregnadienes; Time Factors; Triglycerides | 1988 |
Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Endometriosis; Estradiol; Female; Humans; Laparoscopy; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovulation; Prospective Studies | 1988 |
Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice.
Topics: Animals; Cell Transformation, Neoplastic; Endometriosis; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Organ Size; Precancerous Conditions; Uterine Neoplasms | 1988 |
Steroidal regulation of endometriosis tissue: lack of induction of 17 beta-hydroxysteroid dehydrogenase activity by progesterone, medroxyprogesterone acetate, or danazol.
Topics: 17-Hydroxysteroid Dehydrogenases; Adult; Cell Nucleus; Cytosol; Danazol; Endometriosis; Endometrium; Enzyme Induction; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Pregnadienes; Progesterone; Receptors, Estrogen; Receptors, Progesterone | 1985 |
Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group Study.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Drug Evaluation; Drug Resistance; Endometriosis; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms | 1985 |
Catamenial hemoptysis. New methods of diagnosis and therapy.
Topics: Adult; Danazol; Endometriosis; Female; Hemoptysis; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Radiography, Thoracic; Tomography, X-Ray Computed | 1985 |